| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 341 |
| 1 | ETANERCEPT | 321 |
| 2 | AZATHIOPRINE | 313 |
| 3 | LEFLUNOMIDE | 310 |
| 4 | METHOTREXATE SODIUM | 307 |
| 5 | TOCILIZUMAB | 301 |
| 6 | CERTOLIZUMAB PEGOL | 299 |
| 7 | SULFASALAZINE | 296 |
| 8 | INFLIXIMAB | 280 |
| 9 | METHOTREXATE | 265 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SULFACETAMIDE SODIUM AND SULFUR | 1 | 0.0333 |
| 1 | GOLD | 110 | 0.0277 |
| 2 | DIMETHYL SULFOXIDE | 4 | 0.0234 |
| 3 | PIROXICAM | 84 | 0.0138 |
| 4 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0122 |
| 5 | SULFASALAZINE | 296 | 0.0050 |
| 6 | AZATHIOPRINE | 313 | 0.0049 |
| 7 | CERTOLIZUMAB PEGOL | 299 | 0.0040 |
| 8 | TOCILIZUMAB | 301 | 0.0038 |
| 9 | LEFLUNOMIDE | 310 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 329 |
| 1 | Purine Antimetabolite [EPC] | 313 |
| 2 | Antirheumatic Agent [EPC] | 310 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 301 |
| 4 | Aminosalicylate [EPC] | 297 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 264 |
| 6 | Corticosteroid [EPC] | 117 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 116 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 111 |
| 9 | Standardized Chemical Allergen [EPC] | 110 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Standardized Chemical Allergen [EPC] | 110 | 0.0090 |
| 1 | Purine Antimetabolite [EPC] | 313 | 0.0046 |
| 2 | Antirheumatic Agent [EPC] | 310 | 0.0037 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 301 | 0.0034 |
| 4 | Aminosalicylate [EPC] | 297 | 0.0031 |
| 5 | Iron Chelator [EPC] | 29 | 0.0011 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 111 | 0.0011 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 264 | 0.0008 |
| 8 | Photoenhancer [EPC] | 1 | 0.0007 |
| 9 | Farnesoid X Receptor Agonist [EPC] | 3 | 0.0005 |